Positive Revenue Performance in ADHD Portfolio
Net revenue for the ADHD portfolio increased by approximately 10% year-over-year when excluding a one-time rebate benefit from the previous year, showcasing strong performance against expectations.
EXXUA Launch Progress
The EXXUA launch remains on track for the end of calendar 2025 with significant advancements in KOL engagement, sales force training, and product positioning.
Patent Extension for EXXUA
Successfully extended the EXXUA method of use patent to September 2030, enhancing intellectual property protection.
Strong Cash Position
Cash and cash equivalents were $32.6 million at the end of the quarter, up from $31 million in the previous quarter.